[BrokerRatings]Analyst Ratings Spotlight: Tech and Biotech Lead Strong Buys Amidst Retail Caution

Technology and Biotech sectors lead with multiple strong buy ratings over the past three days. Notable large-cap upgrades include QCOM (market cap ~$173.50B), AMD (market cap ~$273.57B), MDB (market cap ~$25.93B), and OKTA (market cap ~$16.21B). Average target prices suggest continued momentum in these growth areas, aligning with reports of the technology sector leading market gains in July 2025. However, downgrades in retail (GES, SCVL, SKX) and fintech (BILL, market cap ~$5.07B) signal selective caution in consumer-facing and mid-cap growth sectors, despite the broader market setting new highs in August 2025.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top